Ignite Creation Date:
2025-12-26 @ 1:19 PM
Ignite Modification Date:
2025-12-26 @ 1:19 PM
Study NCT ID:
NCT00162006
Status:
COMPLETED
Last Update Posted:
2021-05-03
First Post:
2005-09-08
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Efficacy and Safety Study of a 10% Triple Virally Reduced Intravenous Immune Globulin Solution in Adult Subjects With Chronic Idiopathic Thrombocytopenic Purpura
Sponsor:
Baxalta now part of Shire
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2003-01-13
Start Date Type:
ACTUAL
Primary Completion Date:
2003-12-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2003-12-03
Completion Date Type:
ACTUAL
First Submit Date:
2005-09-08
First Submit QC Date:
None
Study First Post Date:
2005-09-13
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-04-29
Last Update Post Date:
2021-05-03
Last Update Post Date Type:
ACTUAL